RTW Investments, LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 08:41 am Sale | 2025-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW Investments, LP | 5,059,053 8.100% | -256,461 (-4.82%) | Filing |
| 2024-02-14 07:47 am Purchase | 2023-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW Investments, LP | 5,315,514 9.200% | 1,723,528 (+47.98%) | Filing |
| 2023-02-14 10:04 am Purchase | 2022-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW Investments, LP | 3,591,986 7.300% | 992,164 (+38.16%) | Filing |
| 2022-02-14 08:07 am Sale | 2021-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW Investments, LP | 2,599,822 5.400% | -1,050,247 (-28.77%) | Filing |